Special Advisor HTA, Dutch National Health Care Institute (ZIN)
Wim Goettsch, PhD is currently Special Advisor HTA at the Dutch National Health Care Institute He was the Director of the EUnetHTA JA3 (2016-2020) Directorate between June 2016 and March 2018. He also has a position as an affiliate associate professor at Utrecht University (NL). He...
Read More →
Independent Consultant On VBHC
Annemarie Haverhals is an independent healthcare consultant stimulating the implementation of value based healthcare delivery as a way to improve value for patients. Previously she was responsible for the design and implementation of Santeon’s Value Based Healthcare Program (Santeon...
Read More →
Senior Director, Patient and Health Impact, Pfizer
Adam has worked for Pfizer for over 10 years. His current role is Senior Director in Pfizer’s Patient and Health Impact division. Previously, Adam has worked in Pfizer’s international policy division and led Pfizer’s work on science policy in Europe for several years. Adam initially...
Read More →
Chair EUnetHTA Executive Board, Chief Pharmacist, Dental and Pharmaceutical Benefits Agency, TLV
Niklas Hedberg is the Chief Pharmacist at the Swedish national governmental authority, the Dental and Pharmaceuticals Benefits Agency (TLV). He is the Chair of the EUnetHTA Executive Board and the TLV lead partner in EUnetHTA WP 3 Evaluation. Niklas has been working with pricing and...
Read More →
Professor, Pharmaceutical Policy and Regulatory Science, Utrecht University
Hubert (Bert) G. Leufkens is professor of Pharmaceutical Policy and Regulatory Science at Utrecht University. He is research and policy-wise active at several (inter)national platforms on innovation, drug safety, pharmaceutical policy and regulatory science (e.g. past-member EMA Pharmacovigilance...
Read More →